Exabis Library
Welcome to the e-CCO Library!
P283: Predicting outcomes in paediatric Crohn’s disease: A systematic review
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P283: Quantum blue® adalimumab: development of the first point of care rapid test for therapeutic drug monitoring of serum adalimumab levels
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P284 Disentangling fibromyalgia from spondyloarthopathy in the patient with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P284: Assessing Patient Experience in an Inflammatory Bowel Disease service. Can we measure an effect from socioeconomic deprivation – experience from the AWARE-IBD programme?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P284: Assessment of prothrombotic tendency in IBD pregnant patients and its associated risk factors
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P284: Drug survival and remission rates in ustekinumab treated ulcerative colitis: Results from the Swedish Inflammatory Bowel Disease register (SWIBREG)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P284: Jejunal Crohn’s disease: characteristics, detection rate, outcome, and need of immunomodulators in a retrospective single-centre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P284: Prophylactic medication for the prevention of endoscopic recurrence after ileocolonic resection in Crohn’s disease: a prospective study based on clinical risk stratification
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P284: Risk of colorectal neoplasia, colectomy and responsiveness to biologic therapy in patients with inflammatory bowel disease and concomitant primary sclerosing cholangitis: A systematic review
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P284: Ulcerative colitis – presentation during pregnancy or puerperium
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P285 Is faecal immunochemical test a suitable alternative to faecal calprotectin in children?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P285: A retrospective observational study on the effectiveness and safety of vedolizumab with or without budesonide induction therapy among patients with moderate-to-severe Crohn’s disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P285: Correlation between the endoscopic scoring system SES-CD for Crohn's disease with histological and clinical outcomes
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P285: Crohn’s disease overall severity is predictive of disabling disease: Disease severity index evaluation
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P285: Deep learning for automated detection of mucosal inflammation by capsule endoscopy in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P285: Extraintestinal manifestations of Crohn’s disease have a major influence on anxiety levels and coping skills
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P285: Longitudinal single cell transcription profiling of peripheral blood disentangles shared and biologic-specific patterns of early remission in active IBD patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P285: Usefulness of a multidisciplinary approach combining both rheumatology and gastroenterology for the assessment and treatment of inflammatory bowel disease patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P286 Rate of colectomy in ulcerative colitis: Results from a Spanish cohort with 15 years of follow-up
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P286: Bariatric surgery in inflammatory bowel disease: outcome and safety from a GETAID registry population
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM